本頁面由Tiger Trade Technology Pte. Ltd.提供服務

中進醫療

0.1466
+0.00332.30%
盤後0.15240.0058+3.96%18:54 EST
成交量:8.79萬
成交額:1.32萬
市值:2,294.98萬
市盈率:19.27
高:0.1529
開:0.1500
低:0.1446
收:0.1433
52周最高:1.03
52周最低:0.1100
股本:1.57億
流通股本:3,782.45萬
量比:0.56
換手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):0.0076
每股收益(LYR):0.0076
淨資產收益率:4.75%
總資產收益率:0.77%
市淨率:0.77
市盈率(LYR):19.27

資料載入中...

2026/02/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/09/05

SEC問詢函

Form CORRESP - Correspondence
2025/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/21

SEC問詢函

Form CORRESP - Correspondence
2025/03/21

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/01/24

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/03/23

SEC問詢函

Form CORRESP - Correspondence
2023/03/23

SEC問詢函

Form CORRESP - Correspondence
2023/03/21

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/03/07

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/03/07

SEC問詢函

Form CORRESP - Correspondence
2023/02/24

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2022/12/20

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2022/12/01

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2022/12/01

SEC問詢函

Form CORRESP - Correspondence
2022/11/17

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2022/09/13

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]